EZH1/2 as targets for cancer therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Link
https://www.nature.com/articles/s41417-022-00555-1.pdf
Reference88 articles.
1. Lee CH, Yu JR, Kumar S, Jin Y, LeRoy G, Bhanu N, et al. Allosteric activation dictates PRC2 activity independent of its recruitment to chromatin. Mol Cell. 2018;70:422–34.e6.
2. Chen S, Jiao L, Shubbar M, Yang X, Liu X. Unique Structural platforms of SUZ12 dictate distinct classes of PRC2 for chromatin binding. Mol Cell. 2018;69:840–52.e5–.
3. Chammas P, Mocavini I, Di Croce L. Engaging chromatin: PRC2 structure meets function. Br J cancer. 2020;122:315–28.
4. Zhao Y, Guan YY, Zhao F, Yu T, Zhang SJ, Zhang YZ, et al. Recent strategies targeting embryonic ectoderm development (EED) for cancer therapy: allosteric inhibitors, PPI inhibitors, and PROTACs. Eur J Medicinal Chem. 2022;231:114144.
5. Yusufova N, Kloetgen A, Teater M, Osunsade A, Camarillo JM, Chin CR, et al. Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture. Nature. 2021;589:299–305.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dual-target EZH2 inhibitor: latest advances in medicinal chemistry;Future Medicinal Chemistry;2024-07-31
2. Decline in corepressor CNOT1 in the pregnant myometrium near term impairs progesterone receptor function and increases contractile gene expression;Journal of Biological Chemistry;2024-07
3. EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer;Biomedicine & Pharmacotherapy;2024-06
4. Clinical Significance of Upregulation of EZH1 Expression in Hepatocellular Carcinoma Tissues;Journal of Gastrointestinal and Liver Diseases;2024-03-30
5. The competitive mechanism of EZH1 and EZH2 in promoting oral squamous cell carcinoma;Experimental Cell Research;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3